Close-up of IV saline drip.
Our Work

Latham & Watkins Advises on Teleflex Incorporated’s US$500 Million Senior Notes Offering

June 2, 2026
Firm represents the initial purchasers in the offering by the medical technology company.

Teleflex Incorporated (NYSE: TFX) has announced that it priced its private offering of US$500 million aggregate principal amount of 5.875% senior notes due 2032. The offering is expected to close on June 15, 2026, subject to customary closing conditions.

Latham & Watkins LLP represents the initial purchasers in the offering with a corporate team led by New York partners Marc Jaffe and Erika Weinberg, with associates Robyn Sablove and Elana Cates, and assistance from Saiyaz Kazi. Advice was also provided on FDA regulatory matters by Bay Area partner Betty Pang; on healthcare regulatory matters by Washington, D.C. partner Liz Richards, with associate Evan Miller; on data privacy matters by Bay Area partner Heather Deixler, with associate Sarah Zahedi; on EU regulatory matters by Paris/Brussels partner Eveline Van Keymeulen, with associates Grégoire Paquet and Alexis Vaujany; on tax matters by New York partner Greg Hannibal, with associate Sam Yang; on executive compensation and employee benefits matters by New York partner Bradd Williamson, with associate Anne Bracaglia; on banking matters by Chicago partners Zulf Bokhari and John Lister and counsel Stephen Barr, with associates Michael Harris and Darcy Kuang; and on sanctions matters by Washington, D.C. counsel Ruchi Gill, with associate Alexander Perkowski.

Endnotes